Resveratrol |
human melanoma A375 cells |
increase of iNOS, eNOS, and nNOS expression |
[145] |
|
human glaucomatous trabecular meshwork (TM) cells |
decrease of iNOS expression, increase of eNOS expression |
[146] |
|
human endothelial HUVEC cells |
increase of eNOS expression, no effects on iNOS |
[147] |
|
aorta from rats under high-fructose corn syrup intervention |
decrease of iNOS expression, increase of eNOS expression |
[149] |
|
type-2 diabetic mice |
decrease of iNOS expression, increase of eNOS expression |
[150] |
|
rat model of myocardial infarction |
increase of eNOS and iNOS expression |
[151] |
|
rat liver, kidney, and ileum |
increase of eNOS and iNOS expression |
[152] |
Piceatannol |
rat H9c2 cardiomyocytes challenged with H2O2
|
activation of PI3K-Akt-eNOS pathway, decrease of iNOS expression |
[148] |
Quercetin |
liver of juvenile blunt-snout bream fed a high-fat diet |
decrease of iNOS expression, increase of eNOS expression |
[153] |
Rutin |
rat liver after ischemia-reperfusion (I/R) |
decrease of iNOS expression, increase of eNOS expression |
[154] |
EGCG |
rats with gastric ulceration |
decrease of iNOS expression, increase of eNOS expression |
[155] |
epicatechin |
bovine aortic endothelial cell challenged with oxLDL |
decrease of iNOS expression, increase of eNOS expression |
[156] |
lycochalcone C |
rat H9c2 cardiomyocytes challenged with LPS |
upregulation of the PI3K/Akt/eNOS signaling pathway, decrease of iNOS expression |
[157] |
curcumin |
cavernous tissues from diabetic rats |
increase of nNOS and eNOS expression, decrease of iNOS expression |
[158] |